RS Technologies (3445) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Nov, 2026Executive summary
9M 2026 net sales rose 11.0% YoY to ¥65,021 million; operating income increased 13.9% to ¥12,599 million, with full-year guidance unchanged.
Higher 8-inch prime wafer and silicon parts sales supported growth; wafer reclaim margins faced temporary costs and higher depreciation, while semiconductor-related equipment and materials weakened YoY.
Comprehensive income was ¥17,032 million, versus ¥5,355 million in 9M 2025.
Financial highlights
Net sales were ¥65,021 million, up 11.0% YoY; gross profit was ¥20,182 million, up 12.1% and versus ¥18,008 million in 9M 2025.
Ordinary income rose 10.5% YoY to ¥13,276 million; net income attributable to owners of parent increased 18.7% to ¥7,917 million.
Basic EPS was ¥297.86, up 18.1% YoY; diluted EPS was ¥297.26 versus ¥251.19 in 9M 2025.
Outlook and guidance
FY2026 forecast remains unchanged: sales ¥84,000 million, operating income ¥15,400 million, ordinary income ¥17,200 million and net profit ¥10,000 million; forecast basic EPS is ¥376.54.
FY2026 dividend is planned at ¥55 per share, ¥10 higher YoY; medium-term plan targets FY2028 sales of ¥115,000 million and operating income of ¥19,000 million.
Wafer reclaim capacity is planned to reach 1.19 million wafers/month by 2028; 8-inch prime wafer capacity targets 300,000/month in 2026.
Latest events from RS Technologies
- H1 revenue rose 15.1%, but operating income fell 4.9%; FY guidance was unchanged.3445
Q2 2024 - Q1 sales rose 26.4% as operating income fell 12.6%; FY2024 dividend forecast is ¥35 per share.3445
Q1 2024 - 9M sales rose 12.8%, led by reclaimed wafers; FY2026 upside sales target: ¥131.1bn.3445
Q3 2024 - Record FY2024 growth; FY2025 revenue guidance rises as net income is forecast lower.3445
Q4 2024 - H1 sales and operating income grew, but FX and translation effects weighed on earnings.3445
Q2 2025 - Wafer growth lifted sales and operating income, while comprehensive income swung to a loss.3445
Q1 2025 - 9M sales rose 31.5%, while prime wafer pricing pressure contrasted with expansion plans.3445
Q3 2025 - Record FY2025 results support reclaimed-wafer expansion and FY2028 growth targets.3445
Q4 2025 - Q1 earnings rose as reclaimed-wafer growth and currency gains lifted results.3445
Q1 2026